Datamonitor, July 2011, Pages: 36
breastcancer
Arimidex (anastrozole; AstraZeneca)
HER2-positive breastcancer
Herceptin
Triple-negative breastcancer
Chemotherapy regimens are used to treat triple-negative breast
Global Industry Analysts, Inc., Oct 2011, Pages: 897
be used for other types. Biotechnology-based cancerdrugs, including Avastin, Herceptin, and Gleevec are developed based on monoclonal antibodies for treating Chronic Myeloid Leukemia and BreastCancer
Spectra Intelligence, April 2006, Pages: 369
for Advanced Lung Cancer
Table 3.8 Chemotherapy Drugs Most Commonly Used to Treat Colorectal Cancer
Table 3.9 BreastCancer Chemotherapy Treatment Options
Table 3.10 Hormonal Therapies Used in the Treatment
Decision Resources, Inc., Dec 2009, Pages: 34
and Constraints
Sidebar
Common Targets of Targeted Oncology Drugs
Tables
1. Select Cancer Indications Treated with Targeted Drugs
2. Targeted Oncology DrugClasses Commonly Used to Treat Various Cancer
UBM Canon, Aug 2010, Pages: 233
the likelihood of breastcancer returning within five to 10 years after a woman's initial cancer. Groundwork Laid for Orphan Drug Success Industry experts estimate that orphan drugs bring in about $40 billion
GBI Research, Dec 2010, Pages: 126
’s Lymphoma (NHL).
High Growth Rate and Increasing use of Biologics has made the Oncology Market Attractive
The overall market for five indications - breastcancer, colorectal cancer, prostate cancer, lung
TriMark Publications, March 2011, Pages: 309
and Materials Women with MBC value 42
Table 3.11: Classes of Tests Used to TreatBreastCancer 45
Table 3.12: Silicone vs. Silicone Implants 57
Table 3.13: Factors That Increase the Relative Risk for Breast
Informa Healthcare, Jan 2006, Pages: 170
to hormonal/endocrine therapy, the three other classes of drug therapies relevant to breastcancer are “innovative therapy,” “immunotherapy,” and chemotherapy. Innovative and immunotherapy represent a new
TriMark Publications, July 2011, Pages: 267
.8: Herceptin Worldwide Sales, 2000-2015 23
Table 2.9: Classes of DrugsUsed to TreatBreastCancer 23
Table 3.1: Tumor Biomarkers Currently in Common Use 27
Table 3.2: Global IVD Cancer Tumor Marker Testing
TriMark Publications, May 2008, Pages: 182
.3: Medicines in Development for Brain Cancer 72
Table 5.4: Classes of Chemotherapy DrugsUsed to TreatBreastCancer 74
Table 5.5: U.S. Sales of Doxorubicin, 2001-2009 76
Table 5.6: New Therapeutics for Breast
Life Science Intelligence, Inc., Jan 2011
-operative surgical probe used in diagnosing, staging, and treatingbreastcancer, to reduce residual cancer/repeat surgery after breastcancer lumpectomies
- Biological therapeutics for the treatment
GBI Research, Dec 2011, Pages: 172
in-depth analysis of therapeutic indication, which includes HER2 BreastCancer, Bone Metastases and Bone Loss Due to Cancer Therapy, Relapsing-remitting Multiple Sclerosis (RRMS), Metastatic Non-Small Cell
MP Advisors, Aug 2011 class will be marked by the domination of (Glucagon-like Peptide-1) GLP-1 agonist as we expect this class to grow faster than any other class of drugs in the diabetes space. The best in class clinical
Spectra Intelligence, Nov 2006, Pages: 367
and their promise in the treatment of many diverse forms of cancer.
Hormonal anticancer therapeutics are introduced in Chapter 5 as a further important class of drug to successfully treatcancer. The steroid
Datamonitor, April 2010, Pages: 243
trial for triple-negative breastcancer
SWOT analysis
Datamonitor drug assessment summary for BSI-201
Clinical and commercial attractiveness
High potential to alter the treatment landscape for triple
